1. IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells
   Zihui Li et al, 2024, Cellular Signalling CrossRef
2. Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation
   Peter Gál et al, 2022, Histochemistry and Cell Biology CrossRef
3. Evaluation of effects of bisphenol analogs AF, S, and F on viability, proliferation, production of selected cancer-related factors, and expression of selected transcripts in Caov-3 human ovarian epithelial cell line
   Alzbeta Bujnakova Mlynarcikova et al, 2024, Food and Chemical Toxicology CrossRef
4. TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway
   Qiuli Jiang et al, 2023, Immunity, Inflammation and Disease CrossRef
5. Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance
   Marta Ostrowska-Lesko et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
6. Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade
   Pengyuan Kang et al, 2023, Cytokine CrossRef
7. Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites
   Antonio Hrvat et al, 2024, Frontiers in Immunology CrossRef
8. The prohibitin-binding compound fluorizoline induces the pro-inflammatory cytokines interleukin-8 and interleukin-6 through the activation of JNK and p38 MAP kinases
   Ismael Sánchez-Vera et al, 2023, Biochemical Pharmacology CrossRef
9. Interleukin-6 Family of Cytokines in Cancers
   Iwona Zaporowska-Stachowiak et al, 2024, Journal of Interferon & Cytokine Research CrossRef
10. Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs
    Akey Krishna Swaroop et al, 2024, Cytokine & Growth Factor Reviews CrossRef
11. The potential role of interleukins and interferons in ovarian cancer
    Huldani Huldani et al, 2023, Cytokine CrossRef
12. The Effects of Natural Epigenetic Therapies in 3D Ovarian Cancer and Patient-Derived Tumor Explants: New Avenues in Regulating the Cancer Secretome
    Rebeca Kelly et al, 2023, Biomolecules CrossRef
13. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis
    Neda Dadgar et al, 2024, Journal of Translational Medicine CrossRef
14. Targeted Photodynamic Therapy using a Vectorized Photosensitizer coupled to Folic Acid Analog induces Ovarian Tumor Cell Death and inhibits IL-6-mediated Inflammation
    Léa Boidin et al, 2024, Journal of Controlled Release CrossRef
15. Targeting cytokine and chemokine signaling pathways for cancer therapy
    Ming Yi et al, 2024, Signal Transduction and Targeted Therapy CrossRef
16. The CXCR2 chemokine receptor: A new target for gastric cancer therapy
    Wenyan Kang et al, 2024, Cytokine CrossRef